Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
CHATOM PRIMARY CARE, P.C. v. MERCK & CO., INC.
Case Number:
2:12-cv-03555
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Blank Rome
- Fox Rothschild
- Garwin Gerstein
- Glancy Prongay
- Goldman Scarlato
- Kick Law Firm
- Labaton Keller
- Lieff Cabraser
- Miller Shah LLP
- Morgan Lewis
- Mullen Coughlin
- Robins Kaplan
- Spector Roseman
- Spiro Harrison
- Stephan Zouras
- Venable LLP
- Walker Morton
- Weinstein Kitchenoff
- Wilentz Goldman
- Zaremba Brown
- Zwerling Schachter
Companies
Sectors & Industries:
-
March 03, 2017
GSK Won't Produce Docs In Merck Antitrust Suit, Buyers Say
The purchasers suing Merck & Co. Inc. for allegedly lying about the efficacy of its mumps inoculation in order to keep competitors from bringing their own versions of the vaccine told a Pennsylvania federal judge Thursday that GlaxoSmithKline, a third party in the suit, is not cooperating with discovery requests.
-
September 05, 2014
Antitrust, FCA Claims On Merck Mumps Vaccine To Advance
Two lawsuits accusing Merck & Co. Inc. of lying about the efficacy of its mumps inoculation in order to keep competitors from bringing their own versions of the vaccine to market will move forward, after a Pennsylvania federal judge ruled in favor of whistleblowers and direct purchasers Thursday.
-
June 25, 2012
Merck Hit With Antitrust Class Action Over Vaccine Data
Merck and Co. Inc. was hit with a putative antitrust class action in Pennsylvania federal court Friday by an Alabama medical provider alleging the pharmaceutical company lied about the efficacy rate of its mumps inoculation in an effort to keep competitors from bringing their own versions of the vaccine to market.